GERD Recurrence After Laparoscopic Antireflux Surgery

During 5-year follow-up, 18% of surgery recipients had reflux recurrence.

Laparoscopic antireflux surgery (LARS) is one option for treatment of gastroesophageal reflux disease (GERD) in patients who seek an alternative to long-term use of proton-pump inhibitors (PPIs) and want a long-lasting “fix.”

In a population-based, retrospective cohort study in Sweden, researchers evaluated GERD recurrence in more than 2600 patients who underwent LARS (mean age, 51 years) during a 10-year period. Median follow-up was 6 years. Reflux recurrence was defined as performance of repeat LARS or receipt of a dispensed prescription for a PPI or histamine-2-receptor antagonist (H2RA) for at least a 6-month period.

Reflux recurrence occurred in 18% of patients, most of whom (83%) required a postoperative PPI or H2RA prescription for ≥6 …

Reviewing Author

David A. Johnson, MD

Disclosures

Consultant/Advisory boardMedscape/WebMD; Pfizer; CRH Medical Corporation; Aries

EquityCRH Medical Corporation

Editorial boardsMedscape Gastroenterology

Leadership positions in professional societiesAmerican College of Gastroenterology Research Institute Board of Directors